{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:44:44Z","timestamp":1794887084706,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fragile X associated tremor\/ataxia syndrome (FXTAS) is a late adult-onset neurodegenerative disorder that affects movement and cognition in male and female carriers of a premutation allele of 55\u2013200 CGG repeats in the Fragile X mental retardation (<jats:italic>FMR1)<\/jats:italic> gene. It is currently unknown if and when an individual carrier of a premutation allele will develop FXTAS, as clinical assessment fails to identify carriers at risk before significant neurological symptoms are evident. The primary objective of this study was to investigate the alternative splicing landscape at the <jats:italic>FMR1<\/jats:italic> locus in conjunction with brain measures in male individuals with a premutation allele enrolled in a very first longitudinal study, compared to age-matched healthy male controls, with the purpose of identifying biomarkers for early diagnosis, disease prediction and, a progression of FXTAS. Our findings indicate that increased expression of <jats:italic>FMR1<\/jats:italic> mRNA isoforms, including <jats:italic>Iso4\/4b<\/jats:italic>, <jats:italic>Iso10\/10b<\/jats:italic>, as well as of the <jats:italic>ASFMR1 mRNAs Iso131bp<\/jats:italic>, are present in premutation carriers as compared to non-carrier healthy controls. More specifically, we observed a higher expression of <jats:italic>Iso4\/4b and Iso10\/10b,<\/jats:italic> which encode for truncated proteins<jats:italic>,<\/jats:italic> only in those premutation carriers who developed symptoms of FXTAS over time as compared to non-carrier healthy controls, suggesting a potential role in the development of the disorder. In addition, we found a significant association of these molecular changes with various measurements of brain morphology, including the middle cerebellar peduncle (MCP), superior cerebellar peduncle (SCP), pons, and midbrain, indicating their potential contribution to the pathogenesis of FXTAS. Interestingly, the high expression levels of <jats:italic>Iso4\/4b<\/jats:italic> observed both at visit 1 and visit 2 and found to be associated with a decrease in mean MCP width only in those individuals who developed FXTAS over time, suggests their role as potential biomarkers for early diagnosis of FXTAS.<\/jats:p>","DOI":"10.1038\/s41598-020-67946-y","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T10:03:14Z","timestamp":1594029794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor\/ataxia syndrome (FXTAS)"],"prefix":"10.1038","volume":"10","author":[{"given":"Marwa","family":"Zafarullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu-Tung","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blythe","family":"Durbin-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fourie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"67946_CR1","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman, R. J. et al. Fragile X syndrome. Nat. Rev. Dis. Primers. 3, 17065 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"67946_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-0-444-63233-3.00025-7","volume":"147","author":"DA Hall","year":"2018","unstructured":"Hall, D. A. & Berry-Kravis, E. Fragile X syndrome and fragile X-associated tremor ataxia syndrome. Handb. Clin. Neurol. 147, 377\u2013391 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"67946_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fgene.2018.00529","volume":"9","author":"DA Fink","year":"2018","unstructured":"Fink, D. A. et al. Fragile X associated primary ovarian insufficiency (FXPOI): case report and literature review. Front Genet. 9, 529 (2018).","journal-title":"Front Genet."},{"key":"67946_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.460","author":"S Jacquemont","year":"2004","unstructured":"Jacquemont, S. Penetrance of the fragile X\u2013associated tremor\/ataxia syndrome in a premutation carrier population. JAMA. https:\/\/doi.org\/10.1001\/jama.291.4.460 (2004).","journal-title":"JAMA."},{"key":"67946_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/gm401","author":"F Tassone","year":"2012","unstructured":"Tassone, F. et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genom. Med. https:\/\/doi.org\/10.1186\/gm401 (2012).","journal-title":"Genom. Med."},{"key":"67946_CR6","doi-asserted-by":"publisher","DOI":"10.1086\/302720","author":"F Tassone","year":"2000","unstructured":"Tassone, F. et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. https:\/\/doi.org\/10.1086\/302720 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"67946_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.82","author":"RJ Hagerman","year":"2016","unstructured":"Hagerman, R. J. & Hagerman, P. Fragile X-associated tremor\/ataxia syndrome \u2014 features, mechanisms and management. Nat Rev. Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2016.82 (2016).","journal-title":"Nat Rev. Neurol."},{"key":"67946_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.7692601","author":"C Ashley","year":"1993","unstructured":"Ashley, C., Wilkinson, K., Reines, D. & Warren, S. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. https:\/\/doi.org\/10.1126\/science.7692601 (1993).","journal-title":"Science."},{"key":"67946_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/363722a0","author":"C Verheij","year":"1993","unstructured":"Verheij, C. et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. https:\/\/doi.org\/10.1038\/363722a0 (1993).","journal-title":"Nature."},{"key":"67946_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.4.399","author":"AJMH Verkerk","year":"1993","unstructured":"Verkerk, A. J. M. H. et al. Alternative splicing in the fragile X gene FMR1. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/2.4.399 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"67946_CR11","doi-asserted-by":"publisher","unstructured":"Huang, T., Li, L.-Y., Shen, Y., Qin, X.-B., Pang, Z.-L., Wu, G.-Y. Alternative splicing of the FMR1 gene in human fetal brain neurons. Am. J. Med. Genet. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19960809)64:2<252::AID-AJMG3>3.0.CO;2-W (1996).","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<252::AID-AJMG3>3.0.CO;2-W"},{"key":"67946_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.1.95","author":"A Sittler","year":"1996","unstructured":"Sittler, A., Devys, D., Weber, C.-L. & Mandel, J. Alternative splicing of Exon 14 determines nuclear or cytoplasmic localisation of FMR1 protein isoforms. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/5.1.95 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"67946_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nbd.2009.03.015","volume":"35","author":"W Xie","year":"2009","unstructured":"Xie, W., Dolzhanskaya, N., LaFauci, G., Dobkin, C. & Denman, R. B. Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms. Neurobiol. Dis. 35, 52\u201362 (2009).","journal-title":"Neurobiol. Dis."},{"key":"67946_CR14","doi-asserted-by":"publisher","first-page":"e58296","DOI":"10.1371\/journal.pone.0058296","volume":"8","author":"DM Brackett","year":"2013","unstructured":"Brackett, D. M. et al. FMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brain. PLoS ONE 8, e58296 (2013).","journal-title":"PLoS ONE"},{"key":"67946_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102593","author":"DI Pretto","year":"2015","unstructured":"Pretto, D. I. et al. Differential increases of specificFMR1mRNA isoforms in premutation carriers. J. Med. Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102593 (2015).","journal-title":"J. Med. Genet."},{"key":"67946_CR16","doi-asserted-by":"publisher","unstructured":"Tseng, E., Tang, H.-T., AlOlaby, R.R., Hickey, L., Tassone, F. Altered expression of the FMR1 splicing variants landscape in premutation carriers. Biochim. Biophysica Acta (BBA) Gene Regul. Mech. https:\/\/doi.org\/10.1016\/j.bbagrm.2017.08.007. (2017).","DOI":"10.1016\/j.bbagrm.2017.08.007"},{"key":"67946_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.07.083","volume":"514","author":"O Kelemen","year":"2013","unstructured":"Kelemen, O. et al. Function of alternative splicing. Gene 514, 1\u201330 (2013).","journal-title":"Gene"},{"key":"67946_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2018.00012","author":"C-H Su","year":"2018","unstructured":"Su, C.-H., Dhananjaya, D. & Tarn, W.-Y. Alternative splicing in neurogenesis and brain development. Front. Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2018.00012 (2018).","journal-title":"Front. Mol. Biosci."},{"key":"67946_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuron.2015.05.004","volume":"87","author":"B Raj","year":"2015","unstructured":"Raj, B. & Blencowe, B. J. Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles. Neuron 87, 14\u201327 (2015).","journal-title":"Neuron"},{"key":"67946_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/cdd.2016.91","volume":"23","author":"MP Paronetto","year":"2016","unstructured":"Paronetto, M. P., Passacantilli, I. & Sette, C. Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ. 23, 1919\u20131929 (2016).","journal-title":"Cell Death Differ."},{"key":"67946_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1184","author":"D Feng","year":"2013","unstructured":"Feng, D. & Xie, J. Aberrant splicing in neurological diseases. Wiley Interdiscipl. Rev. RNA. https:\/\/doi.org\/10.1002\/wrna.1184 (2013).","journal-title":"Wiley Interdiscipl. Rev. RNA."},{"key":"67946_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1276","author":"B Cieply","year":"2015","unstructured":"Cieply, B. & Carstens, R. P. Functional roles of alternative splicing factors in human disease. Wiley Interdiscipl. Rev. RNA. https:\/\/doi.org\/10.1002\/wrna.1276 (2015).","journal-title":"Wiley Interdiscipl. Rev. RNA."},{"key":"67946_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.molcel.2016.11.033","volume":"64","author":"M Quesnel-Valli\u00e8res","year":"2016","unstructured":"Quesnel-Valli\u00e8res, M. et al. Misregulation of an activity-dependent splicing network as a common mechanism underlying autism spectrum disorders. Mol. Cell. 64, 1023\u20131034 (2016).","journal-title":"Mol. Cell."},{"key":"67946_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-015-0449-x","author":"VL Cognata","year":"2015","unstructured":"Cognata, V. L., La Cognata, V., D\u2019Agata, V., Cavalcanti, F. & Cavallaro, S. Splicing: is there an alternative contribution to Parkinson\u2019s disease?. Neurogenetics. https:\/\/doi.org\/10.1007\/s10048-015-0449-x (2015).","journal-title":"Neurogenetics."},{"key":"67946_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/31508","author":"M Hutton","year":"1998","unstructured":"Hutton, M. et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. https:\/\/doi.org\/10.1038\/31508 (1998).","journal-title":"Nature."},{"key":"67946_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700343104","author":"T Kashima","year":"2007","unstructured":"Kashima, T., Rao, N. & Manley, J. L. An intronic element contributes to splicing repression in spinal muscular atrophy. Proc. Natl. Acad. Sci. https:\/\/doi.org\/10.1073\/pnas.0700343104 (2007).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67946_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/gim.0b013e31822bead0","author":"SB Cassidy","year":"2012","unstructured":"Cassidy, S. B., Schwartz, S., Miller, J. L. & Driscoll, D. J. Prader-Willi syndrome. Genet. Med. https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0 (2012).","journal-title":"Genet. Med."},{"key":"67946_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature07229","volume":"455","author":"H Stefansson","year":"2008","unstructured":"Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232\u2013236 (2008).","journal-title":"Nature"},{"key":"67946_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh327","author":"H Jiang","year":"2004","unstructured":"Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T. & Thornton, C. A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddh327 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"67946_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1154584","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan, J. et al. TDP-43 Mutations in familial and sporadic amyotrophic lateral sclerosis. Science. https:\/\/doi.org\/10.1126\/science.1154584 (2008).","journal-title":"Science."},{"key":"67946_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e3181f07e0c","author":"J Yan","year":"2010","unstructured":"Yan, J. et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia. Neurology. https:\/\/doi.org\/10.1212\/wnl.0b013e3181f07e0c (2010).","journal-title":"Neurology."},{"key":"67946_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0064-4","author":"L Koch","year":"2018","unstructured":"Koch, L. Altered splicing in Alzheimer transcriptomes. Nat. Rev. Genet. https:\/\/doi.org\/10.1038\/s41576-018-0064-4 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"67946_CR33","doi-asserted-by":"publisher","first-page":"e1486","DOI":"10.1371\/journal.pone.0001486","volume":"3","author":"AM Khalil","year":"2008","unstructured":"Khalil, A. M., Faghihi, M. A., Modarresi, F., Brothers, S. P. & Wahlestedt, C. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS ONE 3, e1486 (2008).","journal-title":"PLoS ONE"},{"key":"67946_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00439-013-1356-6","volume":"133","author":"C Pastori","year":"2014","unstructured":"Pastori, C. et al. Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor\/ataxia syndrome. Hum. Genet. 133, 59\u201367 (2014).","journal-title":"Hum. Genet."},{"key":"67946_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm293","author":"PD Ladd","year":"2007","unstructured":"Ladd, P. D. et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddm293 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"67946_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00302","author":"RRA Olaby","year":"2018","unstructured":"Olaby, R. R. A. et al. Assessment of molecular measures in non-FXTAS male premutation carriers. Front. Genet. https:\/\/doi.org\/10.3389\/fgene.2018.00302 (2018).","journal-title":"Front. Genet."},{"key":"67946_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/nxg.0000000000000246","author":"P Vittal","year":"2018","unstructured":"Vittal, P. et al. ASFMR1splice variant. Neurol. Genet. https:\/\/doi.org\/10.1212\/nxg.0000000000000246 (2018).","journal-title":"Neurol. Genet."},{"key":"67946_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/GIM.0b013e3182064362","volume":"13","author":"DZ Loesch","year":"2011","unstructured":"Loesch, D. Z. et al. Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet. Med. 13, 392\u2013399 (2011).","journal-title":"Genet. Med."},{"key":"67946_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00379","author":"AL Shelton","year":"2018","unstructured":"Shelton, A. L. et al. Middle cerebellar peduncle width\u2014a novel MRI biomarker for FXTAS?. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00379 (2018).","journal-title":"Front. Neurosci."},{"key":"67946_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrn1953","volume":"7","author":"N Ramnani","year":"2006","unstructured":"Ramnani, N. The primate cortico-cerebellar system: anatomy and function. Nat. Rev. Neurosci. 7, 511\u2013522 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"67946_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00612","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh, F. N. & Surguchov, A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00612 (2018).","journal-title":"Front. Neurosci."},{"key":"67946_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4088\/JCP.v67n0112","volume":"67","author":"S Bacalman","year":"2006","unstructured":"Bacalman, S. et al. Psychiatric phenotype of the fragile X-associated tremor\/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J. Clin. Psychiat. 67, 87\u201394 (2006).","journal-title":"J. Clin. Psychiat."},{"key":"67946_CR43","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.070073","author":"F Tassone","year":"2008","unstructured":"Tassone, F., Pan, R., Amiri, K., Taylor, A. K. & Hagerman, P. J. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagnost. https:\/\/doi.org\/10.2353\/jmoldx.2008.070073 (2008).","journal-title":"J. Mol. Diagnost."},{"key":"67946_CR44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","volume":"56","author":"S Filipovic-Sadic","year":"2010","unstructured":"Filipovic-Sadic, S. et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin. Chem. 56, 399\u2013408 (2010).","journal-title":"Clin. Chem."},{"key":"67946_CR45","doi-asserted-by":"publisher","unstructured":"Tassone, F., Hagerman, R. J., Chamberlain, W. D., Hagerman, P. J. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am. J. Med. Genet. https:\/\/doi.org\/10.1002\/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R (2000).","DOI":"10.1002\/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R"},{"key":"67946_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.02.030","author":"BA Ardekani","year":"2009","unstructured":"Ardekani, B. A. & Bachman, A. H. Model-based automatic detection of the anterior and posterior commissures on MRI scans. NeuroImage. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.02.030 (2009).","journal-title":"NeuroImage."},{"key":"67946_CR47","doi-asserted-by":"publisher","unstructured":"Mori, S., Crain, B. J., Chacko, V. P., Van Zijl, P. C. M. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann. Neurol. p. 265\u20139. https:\/\/doi.org\/10.1002\/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3 (1999).","DOI":"10.1002\/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3"},{"key":"67946_CR48","doi-asserted-by":"publisher","unstructured":"Tustison, N. J., Avants, B. B., Cook, P. A., Zheng, Y., Egan, A., Yushkevich, P. A., et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging. p. 1310\u201320. Available from: https:\/\/doi.org\/10.1109\/tmi.2010.2046908. (2010).","DOI":"10.1109\/tmi.2010.2046908"},{"key":"67946_CR49","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2453061703","author":"A Quattrone","year":"2008","unstructured":"Quattrone, A. et al. MR imaging index for differentiation of progressive supranuclear palsy from parkinson disease and the parkinson variant of multiple system atrophy. Radiology. https:\/\/doi.org\/10.1148\/radiol.2453061703 (2008).","journal-title":"Radiology."},{"key":"67946_CR50","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2393050459","author":"G Nicoletti","year":"2006","unstructured":"Nicoletti, G. et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from parkinson disease. Radiology. https:\/\/doi.org\/10.1148\/radiol.2393050459 (2006).","journal-title":"Radiology."},{"key":"67946_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.11.024","author":"AD Althouse","year":"2016","unstructured":"Althouse, A. D. Adjust for multiple comparisons? It\u2019s not that simple. Ann. Thorac. Surg. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.11.024 (2016).","journal-title":"Ann. Thorac. Surg."},{"key":"67946_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2018.1543616","author":"SH Hurlbert","year":"2019","unstructured":"Hurlbert, S. H., Levine, R. A. & Utts, J. Coup de gr\u00e2ce for a tough old bull: \u201cstatistically significant\u201d expires. Am. Stat. https:\/\/doi.org\/10.1080\/00031305.2018.1543616 (2019).","journal-title":"Am. Stat."},{"key":"67946_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ng.259","author":"Q Pan","year":"2008","unstructured":"Pan, Q., Shai, O., Lee, L. J., Frey, B. J. & Blencowe, B. J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. https:\/\/doi.org\/10.1038\/ng.259 (2008).","journal-title":"Nat Genet."},{"key":"67946_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ng0793-244","author":"CT Ashley","year":"1993","unstructured":"Ashley, C. T. et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG\u2013repeat. Nat. Genet. https:\/\/doi.org\/10.1038\/ng0793-244 (1993).","journal-title":"Nat. Genet."},{"key":"67946_CR55","first-page":"241","volume":"19","author":"J Ding","year":"1997","unstructured":"Ding, J., Huang, T., Li, L. & Fan, Y. Shen Y [Alternative splicing of the FMR1 gene in human fetal tissues]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 19, 241\u2013246 (1997).","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"67946_CR56","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.6369-09.2010","author":"P Banerjee","year":"2010","unstructured":"Banerjee, P. et al. Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein. J. Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.6369-09.2010 (2010).","journal-title":"J. Neurosci."},{"key":"67946_CR57","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3574","author":"X Fu","year":"2015","unstructured":"Fu, X. et al. Alternatively spliced products lacking exon 12 dominate the expression of fragile X mental retardation 1 gene in human tissues. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2015.3574 (2015).","journal-title":"Mol. Med. Rep."},{"key":"67946_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0076-6","author":"U Saeed","year":"2017","unstructured":"Saeed, U. et al. Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts. Transl. Neurodegener. https:\/\/doi.org\/10.1186\/s40035-017-0076-6 (2017).","journal-title":"Transl. Neurodegener."},{"key":"67946_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2017.10.020","volume":"46","author":"S Mangesius","year":"2018","unstructured":"Mangesius, S. et al. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat. Disord. 46, 47\u201355 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"67946_CR60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell, J. L. et al. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?. Mov. Disord. 32, 955\u2013971 (2017).","journal-title":"Mov. Disord."},{"key":"67946_CR61","doi-asserted-by":"publisher","DOI":"10.1097\/wnr.0000000000000362","author":"JH Lee","year":"2015","unstructured":"Lee, J. H., Ryan, J., Andreescu, C., Aizenstein, H. & Lim, H. K. Brainstem morphological changes in Alzheimer\u2019s disease. NeuroReport. https:\/\/doi.org\/10.1097\/wnr.0000000000000362 (2015).","journal-title":"NeuroReport."},{"key":"67946_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-19966-1_3","author":"R Fernandes","year":"2019","unstructured":"Fernandes, R., Nogueira, G., da Costa, P. J., Pinto, F. & Rom\u00e3o, L. Nonsense-mediated mRNA decay in development, stress and cancer. mRNA Metabol. Hum. Disease. https:\/\/doi.org\/10.1007\/978-3-030-19966-1_3 (2019).","journal-title":"mRNA Metabol. Hum. Disease."},{"key":"67946_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0079-z","author":"SR Jaffrey","year":"2018","unstructured":"Jaffrey, S. R. & Wilkinson, M. F. Nonsense-mediated RNA decay in the brain: emerging modulator of neural development and disease. Nat. Rev. Neurosci.. https:\/\/doi.org\/10.1038\/s41583-018-0079-z (2018).","journal-title":"Nat. Rev. Neurosci.."},{"key":"67946_CR64","doi-asserted-by":"publisher","DOI":"10.4161\/pri.18989","author":"C Korth","year":"2012","unstructured":"Korth, C. Aggregated proteins in schizophrenia and other chronic mental diseases. Prion. https:\/\/doi.org\/10.4161\/pri.18989 (2012).","journal-title":"Prion."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67946-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:38:34Z","timestamp":1670333914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67946-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67946"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67946-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"29 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Flora Tassone received funding from Zynerba\u00a0and\u00a0Azrieli Foundation for carrying out studies in Fragile X Syndrome. Dr. David Hessl received the funding from\u00a0Zynerba and Ovid Therapeutics regarding fragile X\u00a0syndrome clinical trials. The other authors authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11099"}}